ENCHANT

What this means for you

Not registered yet, but its 30 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98726753

Mark type

Stylized text

Filed

30 Aug 2024

Published for opposition

27 May 2025

Attorney of record

Alyssa M. Worsham

Goods and services

• Class 042 — Scientific and technological services: technical scientific consultation and product development for others in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; development of materials, software, artificial intelligence, chemicals, and pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; research and development of treatment protocols for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in science, chemistry, biology, physics, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, technology, chemical engineering, computer science, medicine and healthcare, and design and optimization of molecules, materials, catalysts, chemicals, and drugs; chemistry consultation services in the nature of drugs, materials, chemicals, and molecular discovery services; product development services; chemical research and chemistry consultation in the field of drug, materials, chemicals, and molecular development; providing online non-downloadable software for simulations for drug, materials, chemicals, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; software as a services (SAAS) services in the nature of hosting software for cloud-based computing for the development of new molecules and designing and discovering molecules, drugs, and other molecular products; research and development of pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; design and development of computer software; providing online non-downloadable computer software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; platform as a service (PAAS) featuring computer software platforms using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; platform as a service (PAAS) featuring artificial intelligence computer software platforms for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; software as a service (SAAS) featuring software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; software as a service (SAAS) featuring artificial intelligence software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; providing online non-downloadable computer software for scientific analysis; providing online non-downloadable software, namely, software for use in designing and developing artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, computational chemistry, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in determining properties or physical characteristics of organic compounds, inorganic compounds, organic materials, inorganic materials; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services; Industrial research services in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; Industrial analysis in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; computer modeling services; scientific research into organic compounds; scientific services, namely, analysis of organic compounds, inorganic compounds, organic materials, inorganic materials; crystal analysis services for scientific research purposes; research in the field of computer natural language processing; medical and scientific research in the field of machine learning and models to evaluate drug compounds pharmacological properties; medical and scientific research services in the field of machine learning models to evaluate bioactivity and pharmacological properties of drug compounds; medical and scientific research services in the field of machine learning models to generate and evaluate drug compounds for specific pharmacological and bioactivity effects and results; medical and scientific research services in the field of machine learning models to evaluate drug compounds and their efficacy and side effects for purposes of clinical trials; medical and scientific research services in the field of machine learning models to generate and evaluate treatment protocols for purposes of clinical trials

Owner

• Iambic Therapeutics, Inc., San Diego, CA, US
• Iambic Therapeutics, Inc., San Diego, CA, US

Prosecution history

• 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 22 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
• 22 Jan 2026 — SOU EXTENSION 1 GRANTED
• 22 Jan 2026 — SOU EXTENSION 1 FILED
• 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
• 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 27 May 2025 — PUBLISHED FOR OPPOSITION
• 21 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 29 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 28 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 28 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 28 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 19 Mar 2025 — NON-FINAL ACTION E-MAILED